Rossi, M.; Damiani, C.; Arisi, M.; Tomasi, C.; Tonon, F.; Venturini, M.; Calzavara-Pinton, P.
Definition of the Clinical Characteristics of Patients with Moderate and Severe Atopic Dermatitis for Whom Narrow-Band UVB (NB-UVB) and Medium-Dose UVA1 Phototherapies Are Still Valuable Treatment Options at the Age of Biologics. J. Clin. Med. 2023, 12, 3303.
https://doi.org/10.3390/jcm12093303
AMA Style
Rossi M, Damiani C, Arisi M, Tomasi C, Tonon F, Venturini M, Calzavara-Pinton P.
Definition of the Clinical Characteristics of Patients with Moderate and Severe Atopic Dermatitis for Whom Narrow-Band UVB (NB-UVB) and Medium-Dose UVA1 Phototherapies Are Still Valuable Treatment Options at the Age of Biologics. Journal of Clinical Medicine. 2023; 12(9):3303.
https://doi.org/10.3390/jcm12093303
Chicago/Turabian Style
Rossi, Mariateresa, Caterina Damiani, Mariachiara Arisi, Cesare Tomasi, Francesco Tonon, Marina Venturini, and Piergiacomo Calzavara-Pinton.
2023. "Definition of the Clinical Characteristics of Patients with Moderate and Severe Atopic Dermatitis for Whom Narrow-Band UVB (NB-UVB) and Medium-Dose UVA1 Phototherapies Are Still Valuable Treatment Options at the Age of Biologics" Journal of Clinical Medicine 12, no. 9: 3303.
https://doi.org/10.3390/jcm12093303
APA Style
Rossi, M., Damiani, C., Arisi, M., Tomasi, C., Tonon, F., Venturini, M., & Calzavara-Pinton, P.
(2023). Definition of the Clinical Characteristics of Patients with Moderate and Severe Atopic Dermatitis for Whom Narrow-Band UVB (NB-UVB) and Medium-Dose UVA1 Phototherapies Are Still Valuable Treatment Options at the Age of Biologics. Journal of Clinical Medicine, 12(9), 3303.
https://doi.org/10.3390/jcm12093303